Related Experiment Video

Updated: Jun 12, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Exosome in renal cell carcinoma progression and implications for targeted therapy

Xinwei Li1,2, Wen Xiao1,2, Hongmei Yang3

  • 1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Oncology
|September 19, 2024
PubMed

Insights

Exosomes show promise for renal cell carcinoma (RCC) targeted therapy. Understanding exosome roles in RCC progression could lead to new therapeutic strategies for this metastatic cancer.

Area of Science:

  • Urology
  • Oncology
  • Cell Biology
  • Nanotechnology

Background:

  • Renal cell carcinoma (RCC) is a urological malignancy with a high metastatic potential.
  • Current targeted therapies for RCC require significant improvement.
  • Exosomes are emerging as key players in cancer progression and potential therapeutic vectors.

Purpose of the Study:

  • To review the fundamental characteristics of exosomes (structure, formation, uptake, function, detection).
  • To elucidate the mechanisms by which exosomes contribute to renal cell carcinoma progression.
  • To explore the potential of exosomes in developing targeted therapies for RCC.

Main Methods:

  • Comprehensive literature review on exosomes and renal cell carcinoma.
  • Classification of exosome-mediated mechanisms driving RCC progression.
  • Analysis of current and future applications of exosomes in RCC targeted therapy.

Main Results:

  • Exosomes play multifaceted roles in promoting RCC progression through various mechanisms.
  • Exosomes have demonstrated potential in targeted drug delivery and as biomarkers.
  • Successful exosome-based strategies in other cancers offer a blueprint for RCC.

Conclusions:

  • Exosomes represent a promising avenue for novel targeted therapies in renal cell carcinoma.
  • Further research into exosome biology and function in RCC is warranted.
  • Harnessing exosomes could significantly advance RCC treatment paradigms.
Keywords:
exosomeextracellular vesiclesrenal cell carcinomatargeted therapytumor progression

More Related Videos

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.2K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.8K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K